IP Verse

Otitopic competitive analysis

Loading summary...

Latest patents of Otitopic opposed by its competitors

Explore Otitopic's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Oct 23, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3613421
May 3, 2023Dry Powder Inhaler And Methods Of Use1
EP3179986
Mar 15, 2023Dry Powder Formulations For Inhalation1
EP3107548
Jul 20, 2022Dry Powder Formulations For Inhalation1

Latest publications and patents of Otitopic New

Explore the latest publications and patents granted to Otitopic, showcasing their recent innovations and technological advancements.

Last updated on: Oct 21, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Otitopic

EP3613421
May 3, 2023Dry Powder Inhaler And Methods Of UseGranted And Under Opposition
EP3179986
Mar 15, 2023Dry Powder Formulations For InhalationGranted And Under Opposition
EP3107548
Jul 20, 2022Dry Powder Formulations For InhalationOpposition Rejected

Latest PTAB cases involving Otitopic

Discover the latest PTAB cases involving Otitopic, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Otitopic with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Oct 23, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases Faced
OTITOPIC - 3 - -
GENERICS UK214 - - -